Added value of CA19-9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy.

Eran van Veldhuisen,Jantien A Vogel,Sjors Klompmaker,Olivier R Busch,Hanneke W M van Laarhoven,Krijn P van Lienden,Johanna W Wilmink,Hendrik A Marsman,Marc G Besselink

HPB（2018）

引用 78|浏览6

暂无评分

摘要

Adding CA19-9 response after induction chemotherapy seems useful in determining which patients with RECIST non-progressive LAPC should undergo exploratory surgery.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要